J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)
India
· Delayed Price · Currency is INR 1,702.30
+2.80 (0.16%)
Jun 6, 2025, 3:29 PM IST
NSE:JBCHEPHARM Revenue
In the fiscal year ending March 31, 2025, J. B. Chemicals & Pharmaceuticals had annual revenue of 39.18B INR with 12.45% growth. J. B. Chemicals & Pharmaceuticals had revenue of 9.49B in the quarter ending March 31, 2025, with 10.18% growth.
Revenue
39.18B
Revenue Growth
+12.45%
P/S Ratio
6.78
Revenue / Employee
7.38M
Employees
5,311
Market Cap
265.49B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 39.18B | 4.34B | 12.45% |
| Mar 31, 2024 | 34.84B | 3.35B | 10.63% |
| Mar 31, 2023 | 31.49B | 7.25B | 29.91% |
| Mar 31, 2022 | 24.24B | 3.82B | 18.69% |
| Mar 31, 2021 | 20.43B | 2.68B | 15.09% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 525.78B |
| Divi's Laboratories | 93.60B |
| Cipla | 271.45B |
| Apollo Hospitals Enterprise | 217.94B |
| Mankind Pharma | 122.07B |
| Zydus Lifesciences | 232.42B |
| Aurobindo Pharma | 317.24B |
| Alkem Laboratories | 129.65B |
J. B. Chemicals & Pharmaceuticals News
- 6 weeks ago - Stocks in news: HDFC Bank, ICICI Bank, Emcure Pharma, TCS, NIIT, Adani Ports, Zydus, Adani Green among top stocks to watch on April 21 - Business Upturn
- 2 months ago - JB Chemicals & Pharma shares slide 6% after large block deal of 5.7% equity - Business Upturn
- 2 months ago - Stocks to watch today: Infosys, Wipro, Ashok Leyland, HUL, Bajaj Finance, BSE, NBCC, UPL, Max Financial, JB Chemicals in focus [27 March] - Business Upturn
- 2 months ago - Stocks to watch today: JB Chemicals, Infosys, Bajaj Finserv, Wipro, Bharat Forge, Marico, Sterlite Technologies in focus on March 26, 2025 - Business Upturn
- 2 months ago - KKR, JB Chemicals promoter, to sell 10% for Rs 2.6k crore - The Times of India
- 2 months ago - JB Chemicals and Pharma: Promoter KKR entity to sell 10.2% stake worth Rs 2,575 crore via block tomorrow - Business Upturn
- 7 months ago - KKR Is Said to Consider Selling $750 Million Stake in JB Pharma - BNN Bloomberg
- 8 months ago - Stocks to Buy This Diwali: Kotak Securities sees JB Chemicals & Pharma reaching ₹2,255, with a 19.2% upside - Business Upturn